2018
DOI: 10.3892/mmr.2018.9343
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic effect of chitosan on CCl4‑induced hepatic fibrosis in rats

Abstract: Chitosan is a linear polysaccharide that is made by treating the chitin shells of shrimp and crustaceans with an alkaline substance, for example sodium hydroxide. Due to its unique physical and chemical properties, chitosan has a wide range of applications in the medical field. Currently, there are no effective treatments for liver fibrosis; therefore, the aim of the present study was to investigate the therapeutic effect of chitosan in a CCl4-induced hepatic fibrosis (HF) rat model. The serum levels of aspart… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
17
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(19 citation statements)
references
References 29 publications
1
17
0
Order By: Relevance
“…The histomicrographs of Group II demonstrated vivid features of acute toxicity in the form of inflammation and extensive tissue damage ( Figure 9 ). The sinusoids were abruptly disturbed, showing that tissue fibrosis and nuclear damage were in most of the hepatocytes, as previously documented [ 51 , 54 ]. The sections from this group demonstrated typical liver injury evidenced by noticeable macrosteatosis, ballooning of several hepatocytes, loss of cytoplasm, and pushing of nuclei towards one side, depicting the cellular necrosis.…”
Section: Resultssupporting
confidence: 70%
“…The histomicrographs of Group II demonstrated vivid features of acute toxicity in the form of inflammation and extensive tissue damage ( Figure 9 ). The sinusoids were abruptly disturbed, showing that tissue fibrosis and nuclear damage were in most of the hepatocytes, as previously documented [ 51 , 54 ]. The sections from this group demonstrated typical liver injury evidenced by noticeable macrosteatosis, ballooning of several hepatocytes, loss of cytoplasm, and pushing of nuclei towards one side, depicting the cellular necrosis.…”
Section: Resultssupporting
confidence: 70%
“…Several chitosan‐based biomaterials have been applied with promising results as drug, cell, and gene delivery vehicles 13 . Wang et al 14 reported that chitosan treatment significantly improved CCl 4 ‐induced hepatic fibrosis, by decreasing the serum levels of AST, ALT, and ALP; improving liver histology, and decreasing the expression levels of collagen type 3 (COL) 3 and alpha‐smooth muscle actin (α‐SMA) and was recommended as an alternative approach for the clinical treatment of hepatic fibrosis. Pretreatment with chitosan nanoparticles exhibited a significant reduction in cadmium chloride‐induced gastric mucosal hemorrhagic injury in a dose‐dependent manner 15 .…”
Section: Introductionmentioning
confidence: 99%
“…This also can explain the observed marked inhibitions in the serum activities of ASAT, ALAT, ALP, and CK, with increasing the dose of chitosan in HFD. These findings could be ascribed to the antioxidant activities of chitosan (Wang et al, 2018) and vitamin E (Rizvi et al, 2014) that improved protection of liver and heart against the adverse effects of fat accumulation. This can be also attributed to the above mentioned ability of chitosan to eliminate fats.…”
Section: Discussionmentioning
confidence: 99%